20/20 Biolabs shareholders approve 10x increase in authorized common stock to 500M shares

20/20 Biolabs, Inc.

Shareholders approved charter amendment raising authorized common stock from 50 million to 500 million shares (10x increase).
Vote totals: 3,028,609 for, 1,155,607 against, 72,621 abstentions at Sept 16 adjourned meeting.
Annual meeting was adjourned Aug 18 after proposal lacked sufficient votes; quorum was met Sept 16.
4,256,837 shares represented (about 35% of 12,251,198 outstanding) constituted a quorum.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.